Citigroup’s Viridian Therapeutics VRDN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$601K Sell
42,992
-92,422
-68% -$1.29M ﹤0.01% 2825
2025
Q1
$1.83M Sell
135,414
-507
-0.4% -$6.83K ﹤0.01% 2148
2024
Q4
$2.61M Buy
135,921
+89,704
+194% +$1.72M ﹤0.01% 1941
2024
Q3
$1.05M Buy
46,217
+19,014
+70% +$433K ﹤0.01% 2531
2024
Q2
$354K Sell
27,203
-320,710
-92% -$4.17M ﹤0.01% 2897
2024
Q1
$6.09M Buy
347,913
+263,626
+313% +$4.62M ﹤0.01% 1136
2023
Q4
$1.84M Sell
84,287
-26,022
-24% -$567K ﹤0.01% 1709
2023
Q3
$1.69M Buy
110,309
+30,564
+38% +$469K ﹤0.01% 1570
2023
Q2
$1.9M Sell
79,745
-88,356
-53% -$2.1M ﹤0.01% 1733
2023
Q1
$4.28M Buy
168,101
+110,746
+193% +$2.82M ﹤0.01% 1178
2022
Q4
$1.68M Buy
57,355
+3,977
+7% +$116K ﹤0.01% 1644
2022
Q3
$1.1M Buy
53,378
+51,514
+2,764% +$1.06M ﹤0.01% 2040
2022
Q2
$22K Sell
1,864
-26,276
-93% -$310K ﹤0.01% 4255
2022
Q1
$520K Buy
28,140
+13,256
+89% +$245K ﹤0.01% 2818
2021
Q4
$294K Buy
+14,884
New +$294K ﹤0.01% 3386
2020
Q1
Sell
-195
Closed -$1K 5217
2019
Q4
$1K Hold
195
﹤0.01% 5057
2019
Q3
$2K Sell
195
-331
-63% -$3.4K ﹤0.01% 4972
2019
Q2
$16K Buy
526
+63
+14% +$1.92K ﹤0.01% 4649
2019
Q1
$19K Buy
463
+6
+1% +$246 ﹤0.01% 4548
2018
Q4
$21K Sell
457
-19
-4% -$873 ﹤0.01% 4399
2018
Q3
$40K Buy
476
+214
+82% +$18K ﹤0.01% 4221
2018
Q2
$25K Buy
262
+107
+69% +$10.2K ﹤0.01% 4300
2018
Q1
$17K Buy
155
+147
+1,838% +$16.1K ﹤0.01% 4302
2017
Q4
$1K Buy
+8
New +$1K ﹤0.01% 4907
2017
Q3
Sell
-1,556
Closed -$302K 4873
2017
Q2
$302K Buy
+1,556
New +$302K ﹤0.01% 2702
2016
Q1
Sell
-2
Closed 5618
2015
Q4
$0 Buy
+2
New ﹤0.01% 5679
2015
Q2
Sell
-6
Closed -$3K 5762
2015
Q1
$3K Buy
6
+4
+200% +$2K ﹤0.01% 5168
2014
Q4
$1K Buy
+2
New +$1K ﹤0.01% 5356